Janssen Pharmaceuticals, Inc. v. Tolmar, Inc.

24-1700 | U.S. Court of Appeals, Federal Circuit

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed April 16, 2024
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Original Case 1:21-cv-01784
Last Updated: 5 months, 2 weeks ago Show Interactive Timeline
Filing Date # Docket Text
6/21/2024
  • Order
ORDER reactivating case under FRAP 4(a)(4). Entry of Appearance is due 07/05/2024. Certificate of Interest is due 07/05/2024. Docketing Statement is due 07/05/2024. Appellant's brief is due 08/20/2024. Service as of this date by the Clerk of Court. [1012648] [MMA] [Entered: 06/21/2024 04:42 PM]
6/21/2024Amended docket sheet and copy of order from United States District Court for the District of Delaware. [1012639] [24-1699, 24-1700] [MMA] [Entered: 06/21/2024 04:31 PM]
4/16/2024
  • Order
ORDER deactivating appeals. Service as of this date by the Clerk of Court. [997937] [24-1699, 24-1700] [MMA] [Entered: 04/16/2024 03:31 PM]
4/16/20242Note to File: The following cases are consolidated: 24-1699 (Lead) with 24-1700 (Cross-Appeal). The parties must file all documents in the lead appeal only. [997932] [24-1699, 24-1700] [MMA] [Entered: 04/16/2024 03:25 PM]
4/16/2024Appeal docketed. Received: 04/12/2024. [997929]
. [MMA] [Entered: 04/16/2024 03:22 PM]